Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Increased lung cancer risk among bricklayers in an Italian population-based case-control study.
Consonni D, De Matteis S, Pesatori AC, Cattaneo A, Cavallo DM, Lubin JH, Tucker M, Bertazzi PA, Caporaso NE, Wacholder S, Landi MT.
Am J Ind Med. 2012 May;55(5):423-8. doi: 10.1002/ajim.22017. Epub 2012 Feb 1.
Related citations
Radiofrequency ablation for stage I non-small cell lung cancer: management of locoregional recurrence.
Lanuti M, Sharma A, Willers H, Digumarthy SR, Mathisen DJ, Shepard JA.
Ann Thorac Surg. 2012 Mar;93(3):921-7; discussion 927-88. Epub 2012 Jan 31.
Error occurred: cannot get document summary
Comparison of vinorelbine plus cisplatin and S-1 plus cisplatin in concurrent chemoradiotherapeutic regimens for unresectable stage III non-small cell lung cancer.
Shukuya T, Takahashi T, Harada H, Akamatsu H, Sakaguchi C, Imai H, Ono A, Nakamura Y, Tsuya A, Kenmotsu H, Naito T, Murakami H, Endo M, Takahashi K, Yamamoto N.
Anticancer Res. 2012 Feb;32(2):675-80.
Impacts of treatment lines and initiation timing of erlotinib for advanced non-small cell lung cancer.
Aoki T, Igawa S, Furuya N, Katagiri M, Hisata J, Tajiri S, Hayama N, Mineshita M, Urano T, Miyazawa T, Masuda N, Abe T.
Anticancer Res. 2012 Feb;32(2):601-8.
The evaluation of E-Cadherin and vimentin as biomarkers of clinical outcomes among patients with non-small cell lung cancer treated with erlotinib as second- or third-line therapy.
Richardson F, Young GD, Sennello R, Wolf J, Argast GM, Mercado P, Davies A, Epstein DM, Wacker B.
Anticancer Res. 2012 Feb;32(2):537-52.
Caveolin-1 attenuates hydrogen peroxide-induced oxidative damage to lung carcinoma cells.
Suchaoin W, Chanvorachote P.
Anticancer Res. 2012 Feb;32(2):483-90.
Revolution in lung cancer: new challenges for the surgical pathologist.
Orenstein JM.
Arch Pathol Lab Med. 2012 Feb;136(2):138. No abstract available.
The effect of breast cancer awareness month on internet search activity--a comparison with awareness campaigns for lung and prostate cancer.
Glynn RW, Kelly JC, Coffey N, Sweeney KJ, Kerin MJ.
BMC Cancer. 2011 Oct 12;11:442.
Diagnosis and management of the solitary pulmonary nodule.
Weir G, Kos S, Burrill J, Salat P, Ho S, Liu D.
BMJ. 2011 Dec 13;343:d4866. doi: 10.1136/bmj.d4866. No abstract available.
2. Tobacco-attributable cancer burden in the UK in 2010.
Parkin DM.
Br J Cancer. 2011 Dec 6;105 Suppl 2:S6-S13. doi: 10.1038/bjc.2011.475. No abstract available.
Prognostic implication of metastasis limited to segmental (level 13) and/or subsegmental (level 14) lymph nodes in patients with surgically resected nonsmall cell lung carcinoma and pathologic N1 lymph node status.
Maeshima AM, Tsuta K, Asamura H, Tsuda H.
Cancer. 2012 Jan 26. doi: 10.1002/cncr.27424. [Epub ahead of print]
Correlations between the percentage of tumor cells showing an ALK (anaplastic lymphoma kinase) gene rearrangement, ALK signal copy number, and response to crizotinib therapy in ALK fluorescence in situ hybridization-positive nonsmall cell lung cancer.
Camidge DR, Theodoro M, Maxson DA, Skokan M, O'Brien T, Lu X, Doebele RC, Barón AE, Varella-Garcia M.
Cancer. 2012 Jan 26. doi: 10.1002/cncr.27411. [Epub ahead of print]
Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer.
Doebele RC, Lu X, Sumey C, Maxson DA, Weickhardt AJ, Oton AB, Bunn PA Jr, Barón AE, Franklin WA, Aisner DL, Varella-Garcia M, Camidge DR.
Cancer. 2012 Jan 26. doi: 10.1002/cncr.27409. [Epub ahead of print]
Lung cancer with translocation in the anaplastic lymphoma kinase gene: A disease within a disease.
Ramalingam SS, Khuri FR.
Cancer. 2012 Jan 26. doi: 10.1002/cncr.27402. [Epub ahead of print] No abstract available.
Non-platinum regimens of gemcitabine plus docetaxel versus platinum-based regimens in first-line treatment of advanced non-small cell lung cancer: a meta-analysis on 9 randomized controlled trials.
Yu Y, Xu X, Du Z, Shi M.
Cancer Chemother Pharmacol. 2012 Feb 2. [Epub ahead of print]
Small non-mucinous bronchioloalveolar carcinoma with anaplastic lymphoma kinase immunoreactivity: a novel ALK fusion gene?
Yamamoto M, Takeuchi K, Shimoji M, Maniwa T, Isaka M, Nakagawa K, Ohde Y, Kondo H, Nakajima T.
Cancer Sci. 2012 Feb;103(2):390-2. doi: 10.1111/j.1349-7006.2011.02136.x.
Urinary levels of volatile organic carcinogen and toxicant biomarkers in relation to lung cancer development in smokers.
Yuan JM, Gao YT, Wang R, Chen M, Carmella SG, Hecht SS.
Carcinogenesis. 2012 Apr;33(4):804-9. Epub 2012 Jan 31.
Diagnostic performance of percutaneous core-needle lung biopsy under CT scan fluoroscopic guidance for pulmonary lesions measuring ≤10 mm.
Yamauchi Y, Izumi Y, Nakatsuka S, Inoue M, Hayashi Y, Kohno M, Ohtsuka T, Anraku M, Goto T, Nomori H.
Chest. 2011 Dec;140(6):1669-70. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on